Quantifying health effects from the combined action of low-level radiation and other environmental agents: can new approaches solve the enigma?

Efforts to assess the quantify deleterious effects from toxicants are directed mainly towards single agents, whereas real world environmental and occupational exposures to natural and anthropogenic agents quite often entail the concomitant presence of several toxicants. These combined exposures may lead to health risks that differ from those expected from simple addition of the individual risks. For example, combined exposures to physical and chemical agents such as radon and smoking or asbestos and smoking produce over-additive effects at exposure levels typical for earlier workplaces. In tumour therapy, the modulation of radiation effects by cytotoxic drugs is widely used to enhance the therapeutic gain. Whether interactions occurring at high exposure levels are important at the low exposure levels set for the public and for modern workplaces is difficult to answer. A scientifically sound extrapolation from these high to low-dose levels should be based on dose-effect relationships of the relevant agents alone and in combination. In general this information is not available. The existing data base on combined effects is rudimentary, mainly descriptive and rarely covers exposure ranges large enough to make direct inferences to present day low-dose exposure situations. In view of the multitude of possible interactions between the large number of potentially harmful agents in the human environment, descriptive approaches will have to be supplemented by the use of mechanistic models for critical health endpoints such as cancer. To generalise and predict the outcome of combined exposures, agents will have to be grouped depending on their physical or chemical mode of action on the molecular and cellular level. Such a grouping must be guided by specific mechanistic studies designed to examine the underlying hypothesis regarding how various classes of agents interact.

[1]  A. Han,et al.  Enhanced transformation of mouse 10T1/2 cells by 12-O-tetradecanoylphorbol-13-acetate following exposure to X-rays or to fission-spectrum neutrons. , 1982, Cancer research.

[2]  A. Ootsuyama,et al.  The tumor-initiating and -promoting effects of ionizing radiations in mouse skin. , 1987, Japanese journal of cancer research : Gann.

[3]  P. A. Honchar,et al.  Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1991, The New England journal of medicine.

[4]  J. A. Bond,et al.  Critical issues in benzene toxicity and metabolism: the effect of interactions with other organic chemicals on risk assessment. , 1994, Environmental health perspectives.

[5]  J. Mauderly Toxicological approaches to complex mixtures. , 1993, Environmental health perspectives.

[6]  A. Collins,et al.  Oxidative damage to DNA: do we have a reliable biomarker? , 1996, Environmental health perspectives.

[7]  J. Hendry,et al.  Quantitative Concepts and Dosimetry in Radiobiology , 1980 .

[8]  A. Brooks,et al.  The induction of chromosome damage in CHO cells by beryllium and radiation given alone and in combination. , 1989, Radiation research.

[9]  G K Lam,et al.  The survival response of a biological system to mixed radiations. , 1987, Radiation research.

[10]  C. Streffer,et al.  Radiation Risk from Combined Exposures to Ionizing Radiations and Chemicals , 1984 .

[11]  Lance Wallace,et al.  Personal exposures, indoor and outdoor air concentrations, and exhaled breath concentrations of selected volatile organic compounds measured for 600 residents of New Jersey, North Dakota, North Carolina and California† , 1986 .

[12]  J H Lubin,et al.  Cigarette use and the estimation of lung cancer attributable to radon in the United States. , 1995, Radiation research.

[13]  G. Steel,et al.  Terminology in the description of drug-radiation interactions. , 1979, International journal of radiation oncology, biology, physics.

[14]  Steven F. Arnold,et al.  Synergistic Activation of Estrogen Receptor with Combinations of Environmental Chemicals , 1996, Science.

[15]  Etcyl H. Blair,et al.  Control of Existing Chemicals , 1983 .

[16]  C. Muir,et al.  Environmental carcinogenesis: misconceptions and limitations to cancer control. , 1979, Journal of the National Cancer Institute.

[17]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[18]  B. Ames Mutagenesis and carcinogenesis: Endogenous and exogenous factors , 1989, Environmental and molecular mutagenesis.

[19]  A. Knudson Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[20]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[21]  J. Overgaard,et al.  Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  S. Loewe,et al.  Die quantitativen Probleme der Pharmakologie , 1928 .

[23]  A. Neugut,et al.  Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers , 1994, Cancer.

[24]  C. Borek,et al.  Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Travis,et al.  Background exposure to chemicals: what is the risk? , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[26]  R. Hesketh The Oncogene handbook , 1994 .

[27]  R. L. Carter,et al.  IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man , 1976 .

[28]  K J Rothman,et al.  Synergy and antagonism in cause-effect relationships. , 1974, American journal of epidemiology.

[29]  V. Devita,et al.  IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. , 1980, American Industrial Hygiene Association journal.

[30]  E. Hall,et al.  Modulating factors in the expression of radiation-induced oncogenic transformation. , 1990, Environmental health perspectives.

[31]  F. T. Cross,et al.  Carcinogenic effects of radon daughters, uranium ore dust and cigarette smoke in beagle dogs. , 1982, Health physics.

[32]  Helmut Sigel,et al.  Handbook on toxicity of inorganic compounds , 1990 .

[33]  G. T. Bowden,et al.  Ionizing radiation as an initiator: effects of proliferation and promotion time on tumor incidence in mice. , 1987, Cancer research.

[34]  G. Steel,et al.  Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. , 1979, International journal of radiation oncology, biology, physics.

[35]  M Zaider,et al.  The synergistic effects of different radiations. , 1980, Radiation research.

[36]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[37]  E. C. Hammond,et al.  MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976 * , 1979, Annals of the New York Academy of Sciences.

[38]  H. Bartelink,et al.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.

[39]  Jerome O. Nriagu,et al.  A global assessment of natural sources of atmospheric trace metals , 1989, Nature.

[40]  S. Loewe The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.

[41]  B. Scott Methodologies for predicting the expected combined stochastic radiobiological effects of different ionizing radiations and some applications. , 1984, Radiation research.

[42]  G. B. Gori,et al.  Contribution of the environment to cancer incidence: an epidemiologic exercise. , 1977, Journal of the National Cancer Institute.